Heidelberg Pharma AG, DE000A11QVV0

Heidelberg Pharma AG, DE000A11QVV0

07.09.2022 - 17:48:27

Heidelberg Pharma AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: Heidelberg Pharma AG Street: Gregor-Mendel-Str. 22 Postal code: 68526 City: LadenburgGermany Legal Entity Identifier (LEI): 391200E09XYBYITR1W32 2. Reason for notification X Acquisition/disposal of shares with voting rights ? Acquisition/disposal of instruments X Change of breakdown of voting rights ? Other reason: 3. Details of person subject to the notification obligation Natural person (first name, surname): Daniel HoppDate of birth: 10 Oct 1980 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.dievini Hopp BioTech holding GmbH & Co. KGDH-LT-Investments GmbH 5. Date on which threshold was crossed or reached: 02 Sep 2022 6. Total positions ? % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 43.29 % 0.00 % 43.29 % 46584457 Previous notification 65.33 % 0.00 % 65.33 % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % ? Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000A11QVV0 0 20165703 0.00 % 43.29 % Total 20165703 43.29 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 % ? ? Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0.00 % ? ? ? Total 0 0.00 % 8. Information in relation to the person subject to the notification obligation? Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) -Herr Daniel Hopp % % % -Hopp LT Verm?gensverwaltungs GmbH % % % -DH-Capital GmbH & Co. KG % % % -dievini Hopp BioTech holding GmbH & Co. KG 43.29 % % 43.29 % - % % % -Herr Daniel Hopp % % % -Daniel Hopp Familienstiftung % % % -Hopp LT Verm?gensverwaltungs GmbH % % % -DH-Capital GmbH & Co. KG % % % -dievini Hopp BioTech holding GmbH & Co. KG 43.29 % % 43.29 % - % % % -Herr Daniel Hopp % % % -Dietmar Hopp zweite Familienstiftung % % % -DHFS II Holding GmbH & Co. KG % % % -DH-LT-Investments GmbH 21.04 % % 21.04 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:? Date06 Sep 2022

07.09.2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Heidelberg Pharma AG Gregor-Mendel-Str. 22 68526 Ladenburg

Germany Internet: www.heidelberg-pharma.com ? End of News DGAP News Service

1437171??07.09.2022?CET/CEST

@ dgap.de